We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • My watchlists
  • Help
  • Contact us

Tiziana Life Sciences plc Ordinary 3p

Sell:58.50p Buy:58.50p Change: No change
Market closed |  Prices as at close on 30 November 2021 | Switch to live prices |
Scheme of Arrangement

Tiziana Life Sciences plc Ordinary 3p

Type:
Scheme of Arrangement
Shareholder action required:
Yes
Status:
Update Pending
Details (last updated 17 Sep 2021)

Tiziana Life Sciences is proposing to convert to a Bermuda incorporated company with its shares listed on the NASDAQ stock market in the US. You’ll receive 1 share in the new Bermuda incorporated Tiziana Life Sciences in place of every 2 shares held.

 

As part of the plan, the shares will be delisted from the London Stock Exchange (LSE) on 21 October 2021. From this date, it will only be possible to trade the shares on NASDAQ. The deadline to sell your shares on the LSE via Hargreaves Lansdown is 4.30pm on Friday 15 October 2021.

 

Shareholders will vote on the proposal at meetings on 27 September 2021. 

 

You’ll need to do this by noon on Wednesday 22 September 2021 so we can pass your vote onto the company before the shareholder meetings.

 

Full details of this event will be sent to Qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

 

×
Sell:58.50p
Buy:58.50p
Change: No change
Deal now Deal for just £11.95 per trade in a SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 30 November 2021 | Switch to live prices |
Scheme of Arrangement

Tiziana Life Sciences plc Ordinary 3p

Type:
Scheme of Arrangement
Shareholder action required:
Yes
Status:
Update Pending
Details (last updated 17 Sep 2021)

Tiziana Life Sciences is proposing to convert to a Bermuda incorporated company with its shares listed on the NASDAQ stock market in the US. You’ll receive 1 share in the new Bermuda incorporated Tiziana Life Sciences in place of every 2 shares held.

 

As part of the plan, the shares will be delisted from the London Stock Exchange (LSE) on 21 October 2021. From this date, it will only be possible to trade the shares on NASDAQ. The deadline to sell your shares on the LSE via Hargreaves Lansdown is 4.30pm on Friday 15 October 2021.

 

Shareholders will vote on the proposal at meetings on 27 September 2021. 

 

You’ll need to do this by noon on Wednesday 22 September 2021 so we can pass your vote onto the company before the shareholder meetings.

 

Full details of this event will be sent to Qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

 

×
Sell:58.50p
Buy:58.50p
Change: No change
Market closed |  Prices as at close on 30 November 2021 | Switch to live prices |
Scheme of Arrangement

Tiziana Life Sciences plc Ordinary 3p

Type:
Scheme of Arrangement
Shareholder action required:
Yes
Status:
Update Pending
Details (last updated 17 Sep 2021)

Tiziana Life Sciences is proposing to convert to a Bermuda incorporated company with its shares listed on the NASDAQ stock market in the US. You’ll receive 1 share in the new Bermuda incorporated Tiziana Life Sciences in place of every 2 shares held.

 

As part of the plan, the shares will be delisted from the London Stock Exchange (LSE) on 21 October 2021. From this date, it will only be possible to trade the shares on NASDAQ. The deadline to sell your shares on the LSE via Hargreaves Lansdown is 4.30pm on Friday 15 October 2021.

 

Shareholders will vote on the proposal at meetings on 27 September 2021. 

 

You’ll need to do this by noon on Wednesday 22 September 2021 so we can pass your vote onto the company before the shareholder meetings.

 

Full details of this event will be sent to Qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

 

×
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Open:
n/a
Trade high:
n/a
Year high:
n/a
Market capitalisation
Market cap.
:
n/a
Previous close:
n/a
Trade low:
n/a
Year low:
n/a
P/E ratio:
n/a
Previous:
0.00p (0.00%) Previous:
0.00p
Volume:
n/a
Dividend yield:
n/a
EMS:
n/a
Data delayed by at least 15 minutes.

Share chart Chart

Tiziana Life Sciences plc performance chart

Performance

Not available for this stock.

Dividend information for this stock is not available.

Dividend information for this stock is not available.

Ready to invest?

To buy shares in , you'll need to have an account.
Try our handy filter to explore the different options.

Compare accounts

Ready to invest?

To invest in , you'll need to open an account.
Try our handy filter to find which one suits you best.

Compare accounts

Important Documents

There are no documents available for this stock.

Broker forecasts

Due to changes in how we source investment data, Broker Forecasts are not available. We're sorry for any inconvenience this may cause.

Company news for this stock is not available.

All company announcements

Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.

Annual & interim reports

Annual & interim reports are not available for this stock.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Prices provided by Hargreaves Lansdown. Charts provided by Factset. 'Broker forecast' and 'Recent trades' provided by MoneyAM. News and fundamental data provided by Digital Look.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.